Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034). (Q46021161)
Jump to navigation
Jump to search
scientific article published in May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034). |
scientific article published in May 2009 |
Statements
1 reference
Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034). (English)
1 reference
1 reference
David A Rizzieri
1 reference
Edward A Stadtmauer
1 reference
H Miles Prince
1 reference
Dirk Hönemann
1 reference
Andrew Spencer
1 reference
Nizar Bahlis
1 reference
Guido Tricot
1 reference
Bill Bell
1 reference
Douglas J Demarini
1 reference
A Benjamin Suttle
1 reference
Katherine L Baker
1 reference
Lini N Pandite
1 reference
1 May 2009
1 reference
1 reference
113
1 reference
19
1 reference
4819-4820
1 reference
Identifiers
1 reference